ストックスクリーナーアプリを入手
2.38
3.03%
0.07
アフターアワーズ：
2.34
-0.04
-1.68%
前日終値:
$2.31
開ける：
$2.3
24時間の取引高:
1.15M
Relative Volume:
1.30
時価総額：
$253.04M
収益：
$45.44M
当期純損益:
$-35.43M
株価収益率:
-7.00
EPS:
-0.34
ネットキャッシュフロー:
$-25.39M
1週間 パフォーマンス:
+8.68%
1か月 パフォーマンス:
-18.21%
6か月 パフォーマンス:
-32.96%
1年 パフォーマンス:
-48.82%
1日の値動き範囲:
$2.24
$2.40
1週間の範囲:
$2.18
$2.40
52週間の値動き範囲:
$2.10
$5.26
Maxcyte Inc Stock (MXCT) Company Profile
MXCT を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MXCT
Maxcyte Inc
|
2.38 | 232.84M | 45.44M | -35.43M | -25.39M | -0.34 |
|
ABT
Abbott Laboratories
|
133.58 | 228.44B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
105.26 | 154.60B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
382.64 | 143.93B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
82.98 | 103.43B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.22 | 43.99B | 5.54B | 4.18B | 623.10M | 7.00 |
Maxcyte Inc Stock (MXCT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-11-29 | 開始されました | Craig Hallum | Buy |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2021-08-24 | 開始されました | BTIG Research | Buy |
| 2021-08-24 | 開始されました | Cowen | Outperform |
| 2021-08-24 | 開始されました | Stephens | Overweight |
| 2021-08-24 | 開始されました | Stifel | Buy |
| 2021-08-24 | 開始されました | Wedbush | Outperform |
| 2021-08-24 | 開始されました | William Blair | Outperform |
すべてを表示
Maxcyte Inc (MXCT) 最新ニュース
MaxCyte (NASDAQ:MXCT) Downgraded to “Sell” Rating by Wall Street Zen - Defense World
Deutsche Bank AG Buys 38,782 Shares of MaxCyte, Inc. (NASDAQ:MXCT) - Defense World
MaxCyte Announces Change in Voting Rights Structure - TipRanks
D. E. Shaw & Co. Inc. Buys 84,105 Shares of MaxCyte, Inc. (NASDAQ:MXCT) - Defense World
MaxCyte Announces Change in Major Shareholder Voting Rights - TipRanks
MaxCyte Announces Change in Major Holdings by BlackRock - TipRanks
BlackRock Increases Stake in MaxCyte, Boosting Voting Rights - TipRanks
BlackRock Increases Stake in MaxCyte to 7.65% - TipRanks
Price T Rowe Associates Inc. MD Has $177,000 Position in MaxCyte, Inc. (NASDAQ:MXCT) - Defense World
MaxCyte Announces Change in Major Shareholder Holdings - TipRanks
MaxCyte, Inc. (MXCT): A Bull Case Theory - MSN
MaxCyte Inc (MXCT): Be Patient, You Will Learn - Stocksregister
MaxCyte, Inc. (NASDAQ:MXCT) Q1 2025 Earnings Call Transcript - Insider Monkey
MaxCyte’s Earnings Call: Navigating Challenges and Opportunities - TipRanks
William Blair Predicts MaxCyte’s Q2 Earnings (NASDAQ:MXCT) - Defense World
Hsbc Holdings PLC Purchases 16,554 Shares of MaxCyte, Inc. (NASDAQ:MXCT) - Defense World
MaxCyte Files Form 10-Q for Q1 2025 - TipRanks
BTIG cuts MaxCyte stock price target to $5, maintains Buy rating - Investing.com
MaxCyte, Inc. (MXCT) Reports Q1 Loss, Tops Revenue Estimates - MSN
MaxCyte (MXCT) Upgraded to Buy: Here's What You Should Know - MSN
Earnings call transcript: MaxCyte Q1 2025 beats revenue forecast, stock reacts - Investing.com
Wells Fargo & Company MN Boosts Holdings in MaxCyte, Inc. (NASDAQ:MXCT) - Defense World
MaxCyte Reports First Quarter 2025 Financial Results and Reiterates Full Year 2025 Guidance - The Manila Times
MaxCyte Inc reports results for the quarter ended March 31Earnings Summary - TradingView
MaxCyte Reports Q1 2025 Financial Results Amid Revenue Dip - TipRanks
MaxCyte reports Q1 EPS (10c), consensus (10c) - TipRanks
Financial Fitness Check: Examining MaxCyte Inc (MXCT)’s Key Ratios - DWinneX
A Look at MaxCyte's Upcoming Earnings Report - Nasdaq
MaxCyte Inc expected to post a loss of 11 cents a shareEarnings Preview - TradingView
Invesco Ltd. Has $204,000 Stake in MaxCyte, Inc. (NASDAQ:MXCT) - Defense World
MaxCyte (MXCT) to Release Quarterly Earnings on Wednesday - Defense World
MaxCyte, Inc. (NASDAQ:MXCT) Position Trimmed by Legal & General Group Plc - Defense World
MaxCyte Expands Stock Capital with New Share Issuance - TipRanks
Upward Trajectory: MaxCyte Inc (MXCT) Posts a Slidee, Closing at 2.84 - DWinneX
A stock that deserves closer examination: MaxCyte Inc (MXCT) - uspostnews.com
Renaissance Technologies LLC Has $1.17 Million Stock Position in MaxCyte, Inc. (NASDAQ:MXCT) - Defense World
MaxCyte, Inc. (NASDAQ:MXCT) Shares Sold by JPMorgan Chase & Co. - Defense World
Renaissance Technologies LLC Acquires 91,100 Shares of MaxCyte, Inc. (NASDAQ:MXCT) - The AM Reporter
MaxCyte Announces AIM Delisting to Focus on NASDAQ - TipRanks
MaxCyte Inc (MXCT) requires closer examination - uspostnews.com
BlackRock Adjusts Stake in MaxCyte, Inc. - TipRanks
Vanguard Group Inc. Sells 345,587 Shares of MaxCyte, Inc. (NASDAQ:MXCT) - Defense World
Cooley Advises Cell Therapy Biz On London Market Exit - Law360
MaxCyte intends to delist from London's AIM to enhance liquidity - marketscreener.com
MaxCyte to Delist from AIM, Focus on Nasdaq - TipRanks
MaxCyte, Inc. (NASDAQ:MXCT) Stock Holdings Lifted by American Century Companies Inc. - Defense World
MaxCyte stock plunges to 52-week low of $2.25 amid market challenges By Investing.com - Investing.com South Africa
MaxCyte stock plunges to 52-week low of $2.25 amid market challenges - Investing.com India
Maxcyte Inc (MXCT) 財務データ
収益
当期純利益
現金流量
EPS
0.36%
1.38%
大文字化:
|
ボリューム (24 時間):